EUVIMEDUpptäck EUVIMED
Crossref

In Vitro Permeation Test (IVPT) for Pharmacokinetic Assessment of Topical Dermatological Formulations

Leandro L Santos, Nathaniel J Swofford, Brandon G Santiago

Current Protocols in Pharmacology · 2020-12 · 91 (1)

DOI: 10.1002/cpph.79 ↗

At a glance

Journal article in Current Protocols in Pharmacology, published online on 2020-09-29. Written by Leandro L Santos and 2 co-authors. Institution: Dermatology Unit, Topical Drug Delivery & DMPK, GlaxoSmithKline, Collegeville, Pennsylvania. Major MEDLINE topics: Skin Absorption. Cited 39 times so far (Crossref); 54 references.

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

In vitro assessment of topical (dermal) pharmacokinetics is a critical aspect of the drug development process for semi‐solid products (e.g., solutions, foams, sprays, creams, gels, lotions, ointments), allowing for informed selection of new chemical entities, optimization of prototype formulations during the nonclinical stage, and determination of bioequivalence of generics. It can also serve as a tool to further understand the impact of different excipients on drug delivery, product quality, and formulation microstructure when used in parallel with other techniques, such as analyses of rheology, viscosity, microscopic characteristics, release rate, particle size, and oil droplet size distribution. The in vitro permeation test (IVPT), also known as in vitro skin penetration/permeation test, typically uses ex vivo human skin in conjunction with diffusion cells, such as Franz (or vertical) or Bronaugh (or flow‐through) diffusion cells, and is the technique of choice for dermal pharmacokinetics assessment. Successful execution of the IVPT also involves the development and use of fit‐for‐purpose bioanalytical methods and procedures. The protocols described herein provide detailed steps for execution of the IVPT utilizing flow‐through diffusion cells and for key aspects of the development of a liquid chromatography–tandem mass spectrometry method intended for analysis of the generated samples (epidermis, dermis, and receptor solution). © 2020 Wiley Periodicals LLC. Basic Protocol 1 : In vitro permeation test Support Protocol : Dermatoming of ex vivo human skin Basic Protocol 2 : Bioanalytical methodology in the context of the in vitro permeation test

Subjects

MeSH terms (MEDLINE)

Skin AbsorptionAdministration, CutaneousDermatologic AgentsHumansIn Vitro TechniquesSkin

Author keywords

dermal drug deliveryin vitro permeation test (IVPT)pharmacokineticsskin permeabilitytopical formulation

Substances

Dermatologic Agents

Authors and institutions

  • Dermatology Unit, Topical Drug Delivery & DMPK, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Current affiliation: Incyte Corporation, Inflammation & AutoImmunity, Clinical Research, Wilmington, Delaware.
  • Current affiliation: Functional Genomics, High-Throughput Biology and Imaging, GlaxoSmithKline, Collegeville, Pennsylvania.
  • Current affiliation: Bioanalysis, Drug Metabolism and Pharmacokinetics, GlaxoSmithKline, Collegeville, Pennsylvania.

Cite

APA

Santos, L. L., Swofford, N. J., & Santiago, B. G. (2020). In Vitro Permeation Test (IVPT) for Pharmacokinetic Assessment of Topical Dermatological Formulations. Current Protocols in Pharmacology, 91(1). https://doi.org/10.1002/cpph.79

Vancouver

Santos LL, Swofford NJ, Santiago BG. In Vitro Permeation Test (IVPT) for Pharmacokinetic Assessment of Topical Dermatological Formulations. Current Protocols in Pharmacology. 2020;91(1). doi:10.1002/cpph.79

BibTeX
@article{Santos2020,
  author = {Santos, Leandro L and Swofford, Nathaniel J and Santiago, Brandon G},
  title = {In Vitro Permeation Test (IVPT) for Pharmacokinetic Assessment of Topical Dermatological Formulations},
  journal = {Current Protocols in Pharmacology},
  year = {2020},
  volume = {91},
  number = {1},
  doi = {10.1002/cpph.79}
}
Start for free →